
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM

Intrinsic Value
The intrinsic value of one
RYTM
stock under the Base Case scenario is
59.45
USD.
Compared to the current market price of 62 USD,
Rhythm Pharmaceuticals Inc
is
Overvalued by 4%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Rhythm Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Rhythm Pharmaceuticals Inc
Balance Sheet Decomposition
Rhythm Pharmaceuticals Inc
Current Assets | 369.3m |
Cash & Short-Term Investments | 314.5m |
Receivables | 17.8m |
Other Current Assets | 37m |
Non-Current Assets | 17.4m |
PP&E | 3.8m |
Intangibles | 6m |
Other Non-Current Assets | 7.6m |
Free Cash Flow Analysis
Rhythm Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Rhythm Pharmaceuticals Inc
Revenue
|
162.8m
USD
|
Cost of Revenue
|
-17m
USD
|
Gross Profit
|
145.8m
USD
|
Operating Expenses
|
-458.3m
USD
|
Operating Income
|
-312.5m
USD
|
Other Expenses
|
-2.9m
USD
|
Net Income
|
-315.4m
USD
|
RYTM Profitability Score
Profitability Due Diligence
Rhythm Pharmaceuticals Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Score
Rhythm Pharmaceuticals Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
RYTM Solvency Score
Solvency Due Diligence
Rhythm Pharmaceuticals Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Score
Rhythm Pharmaceuticals Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RYTM Price Targets Summary
Rhythm Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
RYTM
is 85.09 USD
with a low forecast of 72.72 USD and a high forecast of 98.7 USD.
Dividends
Current shareholder yield for RYTM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
RYTM
stock under the Base Case scenario is
59.45
USD.
Compared to the current market price of 62 USD,
Rhythm Pharmaceuticals Inc
is
Overvalued by 4%.